Edwards Lifesciences Book Value Per Share vs. Market Capitalization
| EW Stock | USD 86.96 1.02 1.19% |
Book Value Per Share | First Reported 2010-12-31 | Previous Quarter 10.96093621 | Current Value 11.51 | Quarterly Volatility 3.36018495 |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.54 | 0.7702 |
|
| |||||
| Net Profit Margin | 0.25 | 0.2335 |
|
| |||||
| Operating Profit Margin | 0.16 | 0.2555 |
|
| |||||
| Pretax Profit Margin | 0.14 | 0.2661 |
|
| |||||
| Return On Assets | 0.078 | 0.1498 |
|
| |||||
| Return On Equity | 0.11 | 0.2109 |
|
|
For Edwards Lifesciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Edwards Lifesciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Edwards Lifesciences Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Edwards Lifesciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Edwards Lifesciences Corp over time as well as its relative position and ranking within its peers.
Edwards |
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.3 | Revenue Per Share 9.897 | Quarterly Revenue Growth 0.138 | Return On Assets 0.1225 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Edwards Lifesciences Corp Market Capitalization vs. Book Value Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Edwards Lifesciences's current stock value. Our valuation model uses many indicators to compare Edwards Lifesciences value to that of its competitors to determine the firm's financial worth. Edwards Lifesciences Corp is rated # 3 in book value per share category among related companies. It is one of the top stocks in market capitalization category among related companies creating about 4,675,911,110 of Market Capitalization per Book Value Per Share. At this time, Edwards Lifesciences' Book Value Per Share is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Edwards Lifesciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Edwards Lifesciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Edwards Lifesciences' earnings, one of the primary drivers of an investment's value.Edwards Market Capitalization vs. Book Value Per Share
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Edwards Lifesciences |
| = | 11.06 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Edwards Lifesciences |
| = | 51.73 B |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Edwards Market Capitalization vs Competition
Edwards Lifesciences Corp is one of the top stocks in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 61.42 Billion. Edwards Lifesciences totals roughly 51.73 Billion in market capitalization claiming about 84% of equities under Health Care industry.
Edwards Lifesciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Edwards Lifesciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Edwards Lifesciences will eventually generate negative long term returns. The profitability progress is the general direction of Edwards Lifesciences' change in net profit over the period of time. It can combine multiple indicators of Edwards Lifesciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -242.8 M | -230.7 M | |
| Operating Income | 1.5 B | 1.6 B | |
| Income Before Tax | 1.6 B | 1.7 B | |
| Total Other Income Expense Net | 64 M | 67.2 M | |
| Net Income | 1.4 B | 1.5 B | |
| Income Tax Expense | 198.7 M | 113.1 M | |
| Net Income Applicable To Common Shares | 1.8 B | 1.8 B | |
| Net Income From Continuing Ops | 1.4 B | 836.3 M | |
| Non Operating Income Net Other | 43.8 M | 46 M | |
| Net Interest Income | 40.7 M | 42.7 M | |
| Interest Income | 67.2 M | 70.6 M | |
| Change To Netincome | -56.5 M | -53.6 M | |
| Net Income Per Share | 2.31 | 2.43 | |
| Income Quality | 0.64 | 0.61 | |
| Net Income Per E B T | 0.88 | 0.65 |
Edwards Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Edwards Lifesciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Edwards Lifesciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Edwards Lifesciences' important profitability drivers and their relationship over time.
Use Edwards Lifesciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.Edwards Lifesciences Pair Trading
Edwards Lifesciences Corp Pair Trading Analysis
The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.
The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Edwards Lifesciences position
In addition to having Edwards Lifesciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Electrical Equipment Thematic Idea Now
Electrical Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Electrical Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electrical Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
To fully project Edwards Lifesciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Edwards Lifesciences Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Edwards Lifesciences' income statement, its balance sheet, and the statement of cash flows.